199 research outputs found
Welfare assessment of fatal methaemoglobinaemia in adult rats (Rattus norvegicus)
Gibson, T.J., Gregory, N.G., Quy, R.J., Eason, C.T
PREDICTING THE OUTCOME OF RODENTICIDE TRIALS AGAINST NORWAY RATS LIVING ON FARMS
Difenacoum and bromadiolone treatments against Norway rats may fail because: 1) the animals eat little or no bait, 2) reinvasion rapidly offsets any success, or 3) the population contains resistant individuals. By monitoring bait takes and employing independent measures of rat activity such as tracking plates, it is possible to identify, often in the early stages of a treatment, patterns that indicate the contribution of each of these causes to the eventual outcome. If there is no bait take from the majority of bait points visited by rats in the first week then the treatment is unlikely to be successful, no matter how long it continues. Furthermore, treatments carried out on arable farms, where cereals are stored and the environment is relatively undisturbed, are likely to be less successful than those carried out on livestock farms, where alternative food may also be abundant but where the environment is less predictable. Bait takes that persist at the same bait points for longer than 16 days strongly suggest the presence of resistant rats, while immigration may be significantly affecting the treatment if takes recur at more than 30% of points after a period of seven days. Once a given problem has been identified remedial measures can be taken
Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance.
BACKGROUND: Data on the performance of standardized short-course directly observed treatment (DOTS) of tuberculosis (TB) in areas with high levels of drug resistance and on the potential impact of DOTS on amplification of resistance are limited. Therefore, we analyzed treatment results from a cross-sectional sample of patients with TB enrolled in a DOTS program in an area with high levels of drug resistance in Uzbekistan and Turkmenistan in Central Asia. METHODS: Sputum samples for testing for susceptibility to 5 first-line drugs and for molecular typing were obtained from patients starting treatment in 8 districts. Patients with sputum smear results positive for TB at the end of the intensive phase of treatment and/or at 2 months into the continuation phase were tested again. RESULTS. Among 382 patients with diagnoses of TB, 62 did not respond well to treatment and were found to be infected with an identical Mycobacterium tuberculosis strain when tested again; 19 of these patients had strains that developed new or additional drug resistance. Amplification occurred in only 1.2% of patients with initially susceptible or monoresistant TB strains, but it occurred in 17% of those with polyresistant strains (but not multidrug-resistant strains, defined as strains with resistance to at least isoniazid and rifampicin) and in 7% of those with multidrug-resistant strains at diagnosis. Overall, 3.5% of the patients not initially infected with multidrug-resistant TB strains developed such strains during treatment. Amplification of resistance, however, was found only in polyresistant Beijing genotype strains. CONCLUSIONS: High levels of amplification of drug resistance demonstrated under well-established DOTS program conditions reinforce the need for implementation of DOTS-Plus for multidrug-resistant TB in areas with high levels of drug resistance. The strong association of Beijing genotype and amplification in situations of preexisting resistance is striking and may underlie the strong association between this genotype and drug resistance
Clinical Outcomes of Intraoperative Radiation Therapy for Extremity Sarcomas
Purpose. Radiation of extremity lesions, a key component of limb-sparing therapy, presents particular challenges, with significant risks of toxicities. We sought to explore the efficacy of intraoperative radiation therapy (IORT) in the treatment of soft tissue sarcomas of the extremities. Patients. Between 1995 and 2001, 17 patients received IORT for soft tissue sarcomas of the extremities. Indications for IORT included recurrent tumors in a previously radiated field or tumors adjacent to critical structures. Results. Gross total resections were achieved in all 17 patients. Two patients experienced locoregional relapses, six patients recurred at metastatic sites, and one patient died without recurrence. Thirty-six month estimates for locoregional control, disease free survival, and overall survival were 86%, 50%, and 78%, respectively. IORT was extremely well tolerated, with no toxicities referable to IORT. Conclusions. For patients with soft tissue sarcomas of the extremities, IORT used as a boost to EBRT provides excellent local control, with limited acute toxicities
A blind detection of a large, complex, Sunyaev--Zel'dovich structure
We present an interesting Sunyaev-Zel'dovich (SZ) detection in the first of
the Arcminute Microkelvin Imager (AMI) 'blind', degree-square fields to have
been observed down to our target sensitivity of 100{\mu}Jy/beam. In follow-up
deep pointed observations the SZ effect is detected with a maximum peak
decrement greater than 8 \times the thermal noise. No corresponding emission is
visible in the ROSAT all-sky X-ray survey and no cluster is evident in the
Palomar all-sky optical survey. Compared with existing SZ images of distant
clusters, the extent is large (\approx 10') and complex; our analysis favours a
model containing two clusters rather than a single cluster. Our Bayesian
analysis is currently limited to modelling each cluster with an ellipsoidal or
spherical beta-model, which do not do justice to this decrement. Fitting an
ellipsoid to the deeper candidate we find the following. (a) Assuming that the
Evrard et al. (2002) approximation to Press & Schechter (1974) correctly gives
the number density of clusters as a function of mass and redshift, then, in the
search area, the formal Bayesian probability ratio of the AMI detection of this
cluster is 7.9 \times 10^4:1; alternatively assuming Jenkins et al. (2001) as
the true prior, the formal Bayesian probability ratio of detection is 2.1
\times 10^5:1. (b) The cluster mass is MT,200 = 5.5+1.2\times 10^14h-1M\odot.
(c) Abandoning a physical model with num- -1.3 70 ber density prior and instead
simply modelling the SZ decrement using a phenomenological {\beta}-model of
temperature decrement as a function of angular distance, we find a central SZ
temperature decrement of -295+36 {\mu}K - this allows for CMB primary
anisotropies, receiver -15 noise and radio sources. We are unsure if the
cluster system we observe is a merging system or two separate clusters.Comment: accepted MNRAS. 12 pages, 9 figure
"Author! Author!" : Shakespeare and biography
Original article can be found at: http://www.informaworld.com/smpp/title~content=t714579626~db=all Copyright Informa / Taylor & Francis Group. DOI: 10.1080/17450910902764454Since 1996, not a year has passed without the publication of at least one Shakespeare biography. Yet for many years the place of the author in the practice of understanding literary works has been problematized, and even on occasions eliminated. Criticism reads the “works”, and may or may not refer to an author whose “life” contributed to their meaning. Biography seeks the author in the works, the personality that precedes the works and gives them their characteristic shape and meaning. But the form of literary biography addresses the unusual kind of “life” that puts itself into “works”, and this is particularly challenging where the “works” predominate massively over the salient facts of the “life”. This essay surveys the current terrain of Shakespeare biography, and considers the key questions raised by the medium: can we know anything of Shakespeare's “personality” from the facts of his life and the survival of his works? What is the status of the kind of speculation that inevitably plays a part in biographical reconstruction? Are biographers in the end telling us as much about themselves as they tell us about Shakespeare?Peer reviewe
Animal-related factors associated with moderate-to-severe diarrhea in children younger than five years in western Kenya: A matched case-control study
Background Diarrheal disease remains among the leading causes of global mortality in children younger than 5 years. Exposure to domestic animals may be a risk factor for diarrheal disease. The objectives of this study were to identify animal-related exposures associated with cases of moderate-to-severe diarrhea (MSD) in children in rural western Kenya, and to identify the major zoonotic enteric pathogens present in domestic animals residing in the homesteads of case and control children. Methodology/Principal findings We characterized animal-related exposures in a subset of case and control children (n = 73 pairs matched on age, sex and location) with reported animal presence at home enrolled in the Global Enteric Multicenter Study in western Kenya, and analysed these for an association with MSD. We identified potentially zoonotic enteric pathogens in pooled fecal specimens collected from domestic animals resident at children’s homesteads. Variables that were associated with decreased risk of MSD were washing hands after animal contact (matched odds ratio [MOR] = 0.2; 95% CI 0.08–0.7), and presence of adult sheep that were not confined in a pen overnight (MOR = 0.1; 0.02–0.5). Variables that were associated with increased risk of MSD were increasing number of sheep owned (MOR = 1.2; 1.0–1.5), frequent observation of fresh rodent excreta (feces/urine) outside the house (MOR = 7.5; 1.5–37.2), and participation of the child in providing water to chickens (MOR = 3.8; 1.2–12.2). Of 691 pooled specimens collected from 2,174 domestic animals, 159 pools (23%) tested positive for one or more potentially zoonotic enteric pathogens (Campylobacter jejuni, C. coli, non-typhoidal Salmonella, diarrheagenic E. coli, Giardia, Cryptosporidium, or rotavirus). We did not find any association between the presence of particular pathogens in household animals, and MSD in children. Conclusions and significance Public health agencies should continue to promote frequent hand washing, including after animal contact, to reduce the risk of MSD. Future studies should address specific causal relations of MSD with sheep and chicken husbandry practices, and with the presence of rodents
Recommended from our members
The Hampshire-Berkshire focus of L120Q anticoagulant resistance in the Norway rat (Rattus norvegicus) and field trials of bromadiolone, difenacoum and brodifacoum
Anticoagulant resistance has been present in Norway rats (Rattus norvegicus) in Hampshire and Berkshire for forty years. All first-generation anticoagulants and two of the second generation, bromadiolone and difenacoum, are resisted by rats carrying the L120Q single nucleotide polymorphism (SNP). A regulatory restriction on the use of resistance-breakers brodifacoum, difethialone and flocoumafen in the UK effectively prevented their use against Norway rats for more than 30 years. During this time, L120Q spread from original localised foci eventually to cover most of central-southern England; with other more dispersed foci elsewhere in the UK. We summarise research on L120Q Norway rats and the field performance of anticoagulant baits against them. Bromadiolone (50 ppm), difenacoum (50 ppm) and brodifacoum (23 ppm) baits were each applied on two farmsteads where it had been established that Norway rats carried the L120Q SNP. Preliminary DNA resistance tests conducted at the farms found only one of 107 rats to be susceptible and 86.9% to be homozygous resistant. The bromadiolone and difenacoum applications were either partially or wholly ineffective; brodifacoum treatments were fully effective. Quantities of active substances used varied between farms and substances; but more bromadiolone and difenacoum baits were applied than brodifacoum baits during the treatments. Results confirm the high incidence of resistance and support advice that bromadiolone and difenacoum should not be used against the L120Q SNP. Prolonged use of resisted anticoagulants has resulted in a high prevalence of homozygosity and resistance spread. Failed treatments result in prolonged feeding on anticoagulant bait and leave Norway rats alive carrying, presumably, high residues. It remains to be seen whether the use of now-permitted effective substances, and the introduction of a rodenticide stewardship regime, will curtail the spread of resistance and reduce anticoagulant residues in wildlife
Effects of GnRH vaccination in wild and captive African Elephant bulls (Loxodonta africana) on reproductive organs and semen quality
OBJECTIVES:
Although the African elephant (Loxodonta africana) is classified as endangered by the International
Union for Conservation of Nature (IUCN), in some isolated habitats in southern Africa,
contraception is of major interest due to local overpopulation. GnRH vaccination has been
promoted as a non-invasive contraceptive measure for population management of overabundant
wildlife. We tested the efficacy of this treatment for fertility control in elephant bulls.
METHODS:
In total, 17 male African elephants that were treated with a GnRH vaccine were examined in
two groups. In the prospective study group 1 (n = 11 bulls, ages: 8±36 years), semen quality,
the testes, seminal vesicles, ampullae and prostate, which were all measured by means of
transrectal ultrasound, and faecal androgen metabolite concentrations were monitored over
a three-year period. Each bull in the prospective study received 5 ml of Improvac® (1000 μg
GnRH conjugate) intramuscularly after the first examination, followed by a booster six
weeks later and thereafter every 5±7 months. In a retrospective study group (group 2, n = 6,
ages: 19±33 years), one examination was performed on bulls which had been treated with
GnRH vaccine for 5±11 years.
RESULTS:
In all bulls of group 1, testicular and accessory sex gland sizes decreased significantly after
the third vaccination. In six males examined prior to vaccination and again after more than
five vaccinations, the testis size was reduced by 57.5%. Mean testicular height and length
decreased from 13.3 ± 2.6 cm x 15.2 ± 2.8 cm at the beginning to 7.6 ± 2.1 cm x 10.2 ± 1.8
cm at the end of the study. Post pubertal bulls (>9 years, n = 6) examined prior to vaccination
produced ejaculates with viable spermatozoa (volume: 8±175 ml, sperm concentration:
410-4000x106/ml, total motility: 0±90%), while after 5±8 injections, only 50% of these bulls
produced ejaculates with a small number of immotile spermatozoa. The ejaculates of group
2 bulls (vaccinated >8 times) were devoid of spermatozoa. Faecal androgen metabolite concentrations
measured in captive males decreased significantly after the fourth vaccination.
None of the males entered musth during the treatment period.
CONCLUSIONS:
Our results showed a marked decrease in semen quality, testicle and secondary sex gland
sizes following repeated GnRH vaccinations. After 2±4 years of continuous treatment every
5±7 months, the effects were similar to surgical castration.ISIScopu
- …